Literature DB >> 20179731

Open chromatin and diabetes risk.

Leif Groop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20179731     DOI： 10.1038/ng0310-190

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  13 in total

1.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

Authors:  Valeriya Lyssenko; Roberto Lupi; Piero Marchetti; Silvia Del Guerra; Marju Orho-Melander; Peter Almgren; Marketa Sjögren; Charlotte Ling; Karl-Fredrik Eriksson; Asa-Linda Lethagen; Rita Mancarella; Göran Berglund; Tiinamaija Tuomi; Peter Nilsson; Stefano Del Prato; Leif Groop
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  Nucleosome destabilization in the epigenetic regulation of gene expression.

Authors:  Steven Henikoff
Journal:  Nat Rev Genet       Date:  2008-01       Impact factor: 53.242

3.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

4.  Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent.

Authors:  S C Elbein; W S Chu; S K Das; A Yao-Borengasser; S J Hasstedt; H Wang; N Rasouli; P A Kern
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

5.  A map of open chromatin in human pancreatic islets.

Authors:  Kyle J Gaulton; Takao Nammo; Lorenzo Pasquali; Jeremy M Simon; Paul G Giresi; Marie P Fogarty; Tami M Panhuis; Piotr Mieczkowski; Antonio Secchi; Domenico Bosco; Thierry Berney; Eduard Montanya; Karen L Mohlke; Jason D Lieb; Jorge Ferrer
Journal:  Nat Genet       Date:  2010-01-31       Impact factor: 38.330

6.  Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.

Authors:  Luan Shu; Aleksey V Matveyenko; Julie Kerr-Conte; Jae-Hyoung Cho; Christopher H S McIntosh; Kathrin Maedler
Journal:  Hum Mol Genet       Date:  2009-04-21       Impact factor: 6.150

7.  The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface.

Authors:  Sami Heikkinen; Carmen Argmann; Jérôme N Feige; Hana Koutnikova; Marie-France Champy; Nassim Dali-Youcef; Eric E Schadt; Markku Laakso; Johan Auwerx
Journal:  Cell Metab       Date:  2009-01-07       Impact factor: 27.287

8.  Clinical risk factors, DNA variants, and the development of type 2 diabetes.

Authors:  Valeriya Lyssenko; Anna Jonsson; Peter Almgren; Nicoló Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Göran Berglund; David Altshuler; Peter Nilsson; Leif Groop
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

9.  Tissue-specific alternative splicing of TCF7L2.

Authors:  Ludmila Prokunina-Olsson; Cullan Welch; Ola Hansson; Neeta Adhikari; Laura J Scott; Nicolle Usher; Maurine Tong; Andrew Sprau; Amy Swift; Lori L Bonnycastle; Michael R Erdos; Zhi He; Richa Saxena; Brennan Harmon; Olga Kotova; Eric P Hoffman; David Altshuler; Leif Groop; Michael Boehnke; Francis S Collins; Jennifer L Hall
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

10.  Islet specific Wnt activation in human type II diabetes.

Authors:  Seung-Hee Lee; Carla Demeterco; Ifat Geron; Annelie Abrahamsson; Fred Levine; Pamela Itkin-Ansari
Journal:  Exp Diabetes Res       Date:  2009-01-20
View more
  5 in total

Review 1.  Individualized medicine from prewomb to tomb.

Authors:  Eric J Topol
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

2.  The role of the Wnt signaling pathway in incretin hormone production and function.

Authors:  Yu-Ting A Chiang; Wilfred Ip; Tianru Jin
Journal:  Front Physiol       Date:  2012-07-12       Impact factor: 4.566

3.  The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective.

Authors:  Wilfred Ip; Yu-Ting Alex Chiang; Tianru Jin
Journal:  Cell Biosci       Date:  2012-08-14       Impact factor: 7.133

4.  Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women.

Authors:  Alicia Huerta-Chagoya; Paola Vázquez-Cárdenas; Hortensia Moreno-Macías; Leonardo Tapia-Maruri; Rosario Rodríguez-Guillén; Erika López-Vite; Guadalupe García-Escalante; Fernando Escobedo-Aguirre; Adalberto Parra-Covarrubias; Roberto Cordero-Brieño; Lizette Manzo-Carrillo; Rogelio Zacarías-Castillo; Carlos Vargas-García; Carlos Aguilar-Salinas; Teresa Tusié-Luna
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

5.  Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.

Authors:  Peiwei Chai; Ruobing Jia; Renbing Jia; Hui Pan; Shaoyun Wang; Hongyan Ni; Huixue Wang; Chuandi Zhou; Yingyun Shi; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.